Ubiquitination/ Proteasome
Research Areas
Products Related to Ubiquitination/ Proteasome(1333)
- GC10295Chloroquine diphosphateCAS: 50-63-5Purity: >98.00%
Chloroquine diphosphate is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis.
- GC12391XanthohumolCAS: 6754-58-1Purity: >98.00%
Xanthohumol is the main prenylflavonoid in hops that inhibits diacylglycerol acyltransferase (DGAT) with IC 50 value of 50.3μM.
- GC13166OmeprazoleCAS: 73590-58-6Purity: >98.00%
Omeprazole is an inhibitor of gastric H + /K + ATPase (PPI) with an IC 50 value of 1.1μM for porcine ATPase. Omeprazole has competitive inhibitory effects on CYP2C19 activity with an inhibition constant (Ki) of 2 to 6μM.
- GC15015(±)-Bay K 8644CAS: 71145-03-4Purity: >98.00%
(±)-Bay K 8644 is a dihydropyridine compound that acts as a specific agonist of L-type calcium channels, with an EC₅₀ value of 17.3nM.
- GC15212Divalproex SodiumCAS: 76584-70-8Purity: >98%
Valproic acid (VPA) sodium (2:1) is an orally active HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2.
- GC16587NimodipineCAS: 66085-59-4Purity: >99.00%
Nimodipine is a 1,4-dihydropyridine L-type calcium channel antagonist, mainly used to treat aneurysmal subarachnoid hemorrhage (aSAH) and prevent cerebral vasospasm.
- GC17519Concanamycin ACAS: 80890-47-7Purity: >95.00%
Concanamycin A, a macrolide antibiotic, is a specific inhibitor of vacuolar-type ATPase (V-ATPase) with an IC 50 value of 10nM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10048 | MNS | 1485-00-3 | >98% | |
Inhibitor of Src/Syk tyrosine kinases | ||||
| GC10295 | Chloroquine diphosphate | 50-63-5 | >98.00% | |
Chloroquine diphosphate is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. | ||||
| GC10356 | DUBs-IN-3 | 924296-17-3 | >99.00% | |
DUBs-IN-3 is a potent deubiquitinase (USP) enzyme inhibitor extracted from reference compound 22c with an IC50 of 0.56 μM for USP8. | ||||
| GC10824 | DBeQ | 177355-84-9 | >99.50% | |
P97 ATPase inhibitor | ||||
| GC10970 | WP1130 | 856243-80-6 | >99.50% | |
WP1130 (WP1130) is a cell-permeable deubiquitinase (DUB) inhibitor, directly inhibiting DUB activity of USP9x, USP5, USP14, and UCH37. WP1130 has been shown to downregulate the antiapoptotic proteins Bcr-Abl and JAK2. | ||||
| GC11932 | NSC697923 | 343351-67-7 | >99.00% | |
NSC697923 is a potent, cell-permeable UBE2N (ubiquitin-conjugating enzyme E2 N, Ubc13) inhibitor. | ||||
| GC12003 | VR23 | 1624602-30-7 | >99.00% | |
proteasome inhibitor | ||||
| GC12391 | Xanthohumol | 6754-58-1 | >98.00% | |
Xanthohumol is the main prenylflavonoid in hops that inhibits diacylglycerol acyltransferase (DGAT) with IC 50 value of 50.3μM. | ||||
| GC12622 | HBX 41108 | 924296-39-9 | >98.00% | |
HBX 41108 is a potent inhibitor of USP7 with IC 50 value of 424nM . HBX 41108 is shown to affect USP7-mediated p53 deubiquitinating in vitro and in cells. | ||||
| GC13031 | Trifluoperazine 2HCl | 440-17-5 | >98.00% | |
Dopamine D2 receptor inhibitor | ||||
| GC13166 | Omeprazole | 73590-58-6 | >98.00% | |
Omeprazole is an inhibitor of gastric H + /K + ATPase (PPI) with an IC 50 value of 1.1μM for porcine ATPase. Omeprazole has competitive inhibitory effects on CYP2C19 activity with an inhibition constant (Ki) of 2 to 6μM. | ||||
| GC13401 | SJB3-019A | 2070015-29-9 | >97.00% | |
SJB3-019A is a novel and potent USP1 inhibitor, exhibiting an IC₅₀ value of 0.0781μM in K562 cells. | ||||
| GC13892 | C527 | 192718-06-2 | >99.50% | |
Inhibitor of USP1/USF1 complex | ||||
| GC14577 | Sulfacetamide Sodium | 127-56-0 | >99.50% | |
Sulfonamide antibiotic | ||||
| GC15015 | (±)-Bay K 8644 | 71145-03-4 | >98.00% | |
(±)-Bay K 8644 is a dihydropyridine compound that acts as a specific agonist of L-type calcium channels, with an EC₅₀ value of 17.3nM. | ||||
| GC15212 | Divalproex Sodium | 76584-70-8 | >98% | |
Valproic acid (VPA) sodium (2:1) is an orally active HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. | ||||
| GC15609 | FK 866 hydrochloride | 2727965-45-7 | >98% | |
NMPRTase inhibitor | ||||
| GC15771 | PYR-41 | 418805-02-4 | >98.00% | |
PYR-41 is an irreversible, cell-permeable inhibitor of ubiquitin-activating enzyme E1, with an IC 50 value less than 10μM and minimal effects on E2 and E3. | ||||
| GC15802 | PI-1840 | 1401223-22-0 | >99.00% | |
Chymotrypsin-like (CT-L) inhibitor | ||||
| GC16148 | TAK-242 | 243984-11-4 | >98.00% | |
TAK-242 is a toll-like receptor 4 (TLR4) signaling inhibitor that inhibits NO, TNF-α and IL-6 production with IC 50 values of 1.8nM, 1.9nM and 1.3nM, respectively. | ||||
| GC16587 | Nimodipine | 66085-59-4 | >99.00% | |
Nimodipine is a 1,4-dihydropyridine L-type calcium channel antagonist, mainly used to treat aneurysmal subarachnoid hemorrhage (aSAH) and prevent cerebral vasospasm. | ||||
| GC17125 | DUBs-IN-2 | 924296-19-5 | >98.00% | |
DUBs-IN-2 is a highly selective and membrane-permeable inhibitor for USP8 with IC 50 value of 0.28μM. | ||||
| GC17250 | NMS-873 | 1418013-75-8 | >99.50% | |
VCP/p97 inhibitor,selective and allosteric | ||||
| GC17519 | Concanamycin A | 80890-47-7 | >95.00% | |
Concanamycin A, a macrolide antibiotic, is a specific inhibitor of vacuolar-type ATPase (V-ATPase) with an IC 50 value of 10nM. | ||||
